Results 101 to 110 of about 99,653 (320)

A network analysis to identify pathophysiological pathways distinguishing ischaemic from non-ischaemic heart failure [PDF]

open access: yes, 2019
Aims Heart failure (HF) is frequently caused by an ischaemic event (e.g. myocardial infarction) but might also be caused by a primary disease of the myocardium (cardiomyopathy).
Anker, Stefan D.   +18 more
core   +5 more sources

Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients.

open access: yesJournal of the National Cancer Institute, 2002
BACKGROUND Urokinase-type plasminogen activator (uPA) and its inhibitor (PAI-1) play essential roles in tumor invasion and metastasis. High levels of both uPA and PAI-1 are associated with poor prognosis in breast cancer patients.
M. Look   +39 more
semanticscholar   +1 more source

Effects of SADS‐CoV accessory proteins NS3a, NS7a, and NS7b on viral pathogenicity: A multi‐omics investigation

open access: yesiMetaOmics, EarlyView.
This study has elucidated the role of three swine acute diarrhea syndrome coronavirus (SADS‐CoV) accessory proteins in influencing viral pathogenicity and preliminarily explored the host molecular targets and pathways affected by the NS3a, NS7a, and NS7b proteins of SADS‐CoV.
Xiaoling Yan   +7 more
wiley   +1 more source

Efficacy of AngioJet thrombectomy with sequential low-dose urokinase thrombolysis in the treatment of acute iliofemoral venous thrombosis

open access: yesZhongguo linchuang yanjiu
Objective: To compare the clinical efficacy and safety of AngioJet thrombectomy with sequential low-dose urokinase thrombolysis versus catheter-directed thrombolysis(CDT) in the treatment of acute iliofemoral deep venous thrombosis (DVT).
WANG Youjin, XU Xiangxian, ZHOU Tao, MIAO Qinghai, SHAO Zefeng
doaj   +1 more source

Urokinase and dialysis therapy [PDF]

open access: yesKidney International, 2000
To the Editor: In a recent review by Schwab and Beathard on hemodialysis catheters, the authors did not acknowledge the value of systemic urokinase infusion to open clotted catheters1. Although they admit that the infusion appears to be safe and less expensive than either fibrin sheath stripping or catheter exchange, they also state that the ...
openaire   +2 more sources

The NLRP3 inhibitor NT‐0796 enhances and sustains GLP‐1R agonist‐mediated weight loss in a murine diet‐induced obesity model

open access: yesObesity, EarlyView.
In mouse diet‐induced obesity models, the brain penetrant NLRP3 inhibitor NT‐0796 enhances and sustains the efficacy of the GLP‐1RA semaglutide, leading to a complete reversal of obesity. This correlates with reduced peripheral inflammation and anti‐neuroinflammatory activities, including a reduction in hypothalamic gliosis suggesting further benefits ...
Peter Thornton   +6 more
wiley   +1 more source

Identification of a novel regulatory mechanism for the disease associated protein, uPAR [PDF]

open access: yes, 2014
Expression quantitative trait loci (eQTLs), as determined through a series of statistical association studies collectively known as genome-wide association (GWA) studies, have provided us with a hypothesis free approach for the investigation into ...
Hall, Ian P.   +2 more
core  

Elevated PAI-1 is associated with poor clinical outcomes in pediatric patients with acute lung injury. [PDF]

open access: yes, 2009
PurposeDeposition of fibrin in the alveolar space is a hallmark of acute lung injury (ALI). Plasminogen activator inhibitor-1 (PAI-1) is an antifibrinolytic agent that is activated during inflammation. Increased plasma and pulmonary edema fluid levels of
Brady, Sandra   +4 more
core   +2 more sources

Metabolic Fate of Urokinase

open access: yesChemical and Pharmaceutical Bulletin, 1974
The metabolic fate of 131I-urokinase in rats and dogs was investigated. The radioactivity in the blood of both animals after intravenous administration rapidly decreased in early stage, followed by a slow decrease of the radioactivity. When 131I-urokinase was given into rats by intravenous infusion, the peak of radioactivity in the blood was found at ...
Shingo Tanaka   +5 more
openaire   +4 more sources

A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. Thrombolysis or Peripheral Arterial Surgery (TOPAS) Investigators.

open access: yesNew England Journal of Medicine, 1998
BACKGROUND Recent controlled trials suggest that thrombolytic therapy may be an effective initial treatment for acute arterial occlusion of the legs. A major potential benefit of initial thrombolytic therapy is that limb ischemia can be managed with less
K. Ouriel, F. Veith, A. Sasahara
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy